Non-Alcoholic Steato-Hepatitis

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Non-Alcoholic Steato-Hepatitis trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingNot Applicable

NCT06843148

Stimulating Fat Tissue Storage With Niacin to Reduce Fat Accumulation in the Liver.

Metabolic dysfunction-associated steatotic liver disease (MASLD) (aka non-alcoholic fatty liver disease), commonly occurring in individuals with obesity and typ…

Canada36 participantsStarted 2026-04

Treatment: Niacin (250mg), Placebo Oral Tablet

All recent trials (14 shown)

Active — Not RecruitingNot Applicable

NCT07502755

Non-invasive Tests for Non-alcoholic Steato-hepatitis

The main objective is to study and validate a new approach for NASH and liver fibrosis diagnosis and personalized follow-up based on monocyte biomarkers and pla…

Italy828 participantsStarted 2024-08-31

Treatment: Administration of Deuterated water

Not Yet RecruitingNot Applicable

NCT07133854

How Abnormal Function of Fat Tissue in Type 1 Diabetes Contributes to Fat in the Liver

Steatotic liver disease associated with metabolic dysfunction (MASLD) is a disease caused by excess fat storage in the liver. Excessive fat delivery to the live…

Canada32 participantsStarted 2026-09

Treatment: Imaging PET/MRI, Stable isotope infusions

Non-Alcoholic Steato-Hepatitis

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Stimulating Fat Tissue Storage With Niacin to Reduce Fat Accumulation in the Liver.

All recent trials (14 shown)

Non-invasive Tests for Non-alcoholic Steato-hepatitis

How Abnormal Function of Fat Tissue in Type 1 Diabetes Contributes to Fat in the Liver

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Stimulating Fat Tissue Storage With Niacin to Reduce Fat Accumulation in the Liver.

All recent trials (14 shown)

Non-invasive Tests for Non-alcoholic Steato-hepatitis

How Abnormal Function of Fat Tissue in Type 1 Diabetes Contributes to Fat in the Liver

The TRIABETES - ARMMS-T2D Study: A Randomized Trial to Compare Surgical and Medical Treatments for Type 2 Diabetes

: Identification of Non-alcoholic Steato-hepatitis Cases in a Sample of Type 2 Diabetes Patients, with a Disruption of t…

Bariatric Surgery Versus Non-alcoholic Steato-hepatitis

Sleep Apnoea Syndrome and Hepatocellular Carcinoma

Intragastric Balloon in Compensated NASH(Non Alcoholic Steato Hepatitis) Cirrhotics

Genetic Studies of Non-Alcoholic Fatty Liver Disease

Safety and Tolerability of HepaStem in Patients With Cirrhotic and Pre-cirrhotic NASH Patients

NAFLD Study: US vs Liver Biopsy

Metabolic Surgery for Steato-Hepatitis

Prospective Cohort Assessing the Role of the Genotoxin Colibactin From Escherichia Coli B2 in the Genesis of NASH

Effects of Rosiglitazone and Alpha-lipoic Acid on the Patients With Pathologically Proved NASH